Evidence map›Paper›PMID 23805267›Full record

ArticlePloS one2013

Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome.

Mark Clendenning, Joanne P Young, Michael D Walsh, Sonja Woodall, Julie Arnold, Mark Jenkins, Aung Ko Win, John L Hopper, Kevin Sweet, Steven Gallinger and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Germline mutations inJournal of medical genetics · 2023
    Article
  9. Unraveling the impact of a germline heterozygousFrontiers in molecular biosciences · 2023
    Article
  10. Article
  11. Germline variant testing in serrated polyposis syndrome.Journal of gastroenterology and hepatology · 2022
    Article
  12. Article
  13. Hereditary or Not? Understanding Serrated Polyposis Syndrome.Current treatment options in gastroenterology · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. MYH polyposis syndrome: clinical findings, genetics issues and management.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Mark ClendenningCancer and Population Studies Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
Joanne P Young
Michael D Walsh
Sonja Woodall
Julie Arnold
Mark Jenkins
Aung Ko Win
John L Hopper
Kevin Sweet
Steven Gallinger
Christophe Rosty
Susan Parry
Daniel D Buchanan
QIMR Berghofer Medical Research Institute · AUThe University of Melbourne · AUAuckland City Hospital · NZLunenfeld-Tanenbaum Research Institute · CAMiddlemore Hospital · NZSullivan Nicolaides Pathology · AUThe Ohio State University · US

Funding

AUSTRALASIAN COLORECTAL CANCER FAMILY REGISTRYU01CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2002 to 2007
$6.9M
The Colon Cancer Family Registry: AustralasiaU24CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2008 to 2011
$6.2M
Genetics of Serrated NeoplasiaR01CA123010 · NCI · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI YOUNG, JOANNE PATRICIA · 2007 to 2009
$898k
NCI NIH HHS R01 CA123010NCI NIH HHS U01 CA097735NCI NIH HHS U24 CA097735
6 · The paper itself

Abstract

backgroundRecent reports have observed that individuals with serrated polyps, some of whom meet the clinical diagnostic criteria for Serrated Polyposis Syndrome (SPS), are among those who carry germline mutations in genes associated with polyposis syndromes including; (1) genes known to underlie hamartomatous polyposes (SMAD4, BMPR1A, and PTEN), (2) MUTYH-associated polyposis and (3) GREM1 in Hereditary Mixed Polyposis Syndrome (HMPS). The aim of this study was to characterise individuals fulfilling the current WHO criteria for SPS for germline mutations in these polyposis-associated genes.

methodsA total of 65 individuals with SPS (fulfilling WHO criteria 1 or 3), were recruited to the Genetics of Serrated Neoplasia study between 2000 and 2012, through multiple Genetics or Family Cancer Clinics within Australia, or from the New Zealand Familial Gastrointestinal Cancer Service. Individuals with SPS were tested for coding mutations and large deletions in the PTEN, SMAD4, and BMPR1A genes, for the MUTYH variants in exons 7 (Y179C) and 13 (G396D), and for the duplication upstream of GREM1.

resultsWe found no variants that were likely to be deleterious germline mutations in the SPS cases in the PTEN, SMAD4, and BMPR1A genes. A novel variant in intron 2 (c.164+223T>C) of PTEN was identified in one individual and was predicted by in silico analysis to have no functional consequences. One further individual with SPS was found to be mono-allelic for the MUTYH G396D mutation. No individuals carried the recently reported duplication within GREM1.

conclusionsGenes involved in the gastrointestinal hamartomatous polyposis, Hereditary Mixed Polyposis Syndrome and MUTYH-associated polyposis syndromes are not commonly altered in individuals with SPS.

Indexed as

AdultAgedBone Morphogenetic Protein Receptors, Type IColorectal NeoplasmsDNA GlycosylasesExonsFemaleGene DuplicationGerm-Line MutationHumansIntercellular Signaling Peptides and ProteinsIntronsMaleMiddle AgedNeoplastic Syndromes, HereditaryPTEN PhosphohydrolaseBMPR1A protein, humanBone Morphogenetic Protein Receptors, Type IDNA GlycosylasesGREM1 protein, humanIntercellular Signaling Peptides and ProteinsmutY adenine glycosylasePTEN PhosphohydrolasePTEN protein, humanSmad4 Protein

Identifiers

PMID23805267
PMCPMC3689730
OpenAlexW2053025042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.